Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Buy
65
QQQX Quote, Financials, Valuation and Earnings
Last price:
$26.84
Seasonality move
:
0.33%
Day range:
$26.50 - $26.92
52-week range:
$22.37 - $27.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
117.4K
Avg. volume:
102K
1-year change:
18.12%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNuveen NASDAQ 100 Dynamic Overwrite Fund has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Nuveen NASDAQ 100 Dynamic Overwrite Fund has an estimated downside of -- from its current price of $26.86.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $26.86.
Fair Value
-
According to the consensus of 0 analysts, Nuveen NASDAQ 100 Dynamic Overwrite Fund has -- downside to fair value with a price target of -- per share.
QQQX vs. S&P 500
-
Over the past 5 trading days, Nuveen NASDAQ 100 Dynamic Overwrite Fund has underperformed the S&P 500 by -1.85% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Nuveen NASDAQ 100 Dynamic Overwrite Fund does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nuveen NASDAQ 100 Dynamic Overwrite Fund has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Nuveen NASDAQ 100 Dynamic Overwrite Fund reported revenues of --.
Earnings Growth
-
Nuveen NASDAQ 100 Dynamic Overwrite Fund has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Nuveen NASDAQ 100 Dynamic Overwrite Fund reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-24 | 2023-12-24 | 2023-12-24 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $254K | $391K | $140.9K | |
| Total Assets | -- | -- | $783.1M | $962.4M | $1.1B | |
| Current Liabilities | -- | -- | -- | -- | $332K | |
| Total Liabilities | -- | -- | $16.2M | $10.4M | $15.4M | |
| Total Equity | -- | -- | $766.9M | $951.9M | $1.1B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-24 | 2023-12-24 | 2023-12-24 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
QQQX
Sector
Market Cap
--
--
Price % of 52-Week High
97.67%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
18.12%
--
Beta (5-Year)
1.105
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$26.65
200-day SMA
Buy
Level
$24.70
Bollinger Bands (100)
Buy
Level
24.34 - 26.26
Chaikin Money Flow
Buy
Level
5.8M
20-day SMA
Buy
Level
$26.71
Relative Strength Index (RSI14)
Buy
Level
56.57
ADX Line
Buy
Level
12.84
Williams %R
Neutral
Level
-42.6667
50-day SMA
Buy
Level
$26.05
MACD (12, 26)
Buy
Level
0.16
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
9.4M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Nasdaq 100 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets in an equity portfolio made up of securities comprising the Nasdaq 100 Index (or securities that have economic characteristics that are similar to those securities comprising the Nasdaq 100 Index) that seeks to substantially replicate price movements of the Nasdaq 100 Index and is designed to support the Fund’s option strategy.
Stock Forecast FAQ
In the current month, QQQX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The QQQX average analyst price target in the past 3 months is --.
-
Where Will Nuveen NASDAQ 100 Dynamic Overwrite Fund Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nuveen NASDAQ 100 Dynamic Overwrite Fund share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Nuveen NASDAQ 100 Dynamic Overwrite Fund?
Analysts are divided on their view about Nuveen NASDAQ 100 Dynamic Overwrite Fund share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nuveen NASDAQ 100 Dynamic Overwrite Fund is a Sell and believe this share price will rise from its current level to --.
-
What Is Nuveen NASDAQ 100 Dynamic Overwrite Fund's Price Target?
The price target for Nuveen NASDAQ 100 Dynamic Overwrite Fund over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is QQQX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nuveen NASDAQ 100 Dynamic Overwrite Fund is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of QQQX?
You can purchase shares of Nuveen NASDAQ 100 Dynamic Overwrite Fund via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nuveen NASDAQ 100 Dynamic Overwrite Fund shares.
-
What Is The Nuveen NASDAQ 100 Dynamic Overwrite Fund Share Price Today?
Nuveen NASDAQ 100 Dynamic Overwrite Fund was last trading at $26.84 per share. This represents the most recent stock quote for Nuveen NASDAQ 100 Dynamic Overwrite Fund. Yesterday, Nuveen NASDAQ 100 Dynamic Overwrite Fund closed at $26.86 per share.
-
How To Buy Nuveen NASDAQ 100 Dynamic Overwrite Fund Stock Online?
In order to purchase Nuveen NASDAQ 100 Dynamic Overwrite Fund stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is down 8.7% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is up 9.77% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is up 7.96% over the past day.
